Sectoral Asset Management Inc 13F annual report

Sectoral Asset Management Inc is an investment fund managing more than $246 billion ran by Marina Lalakin. There are currently 97 companies in Mrs. Lalakin’s portfolio. The largest investments include Lilly Eli & Co and Lenz Therapeutics, together worth $39.9 billion.

Limited to 30 biggest holdings

$246 billion Assets Under Management (AUM)

As of 6th August 2024, Sectoral Asset Management Inc’s top holding is 23,415 shares of Lilly Eli & Co currently worth over $21.2 billion and making up 8.6% of the portfolio value. In addition, the fund holds 1,084,404 shares of Lenz Therapeutics worth $18.7 billion. The third-largest holding is Contineum Thera worth $14.1 billion and the next is Unitedhealth Grp Inc worth $13.6 billion, with 26,675 shares owned.

Currently, Sectoral Asset Management Inc's portfolio is worth at least $246 billion. The total portfolio value may be much higher due to cash assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.

Careers at Sectoral Asset Management Inc

The Sectoral Asset Management Inc office and employees reside in Montreal, Quebec, Canada. According to the last 13-F report filed with the SEC, Marina Lalakin serves as the Chief Compliance Officer at Sectoral Asset Management Inc.

Recent trades

In the most recent 13F filing, Sectoral Asset Management Inc revealed that it had opened a new position in Contineum Thera and bought 800,887 shares worth $14.1 billion.

The investment fund also strengthened its position in Lenz Therapeutics by buying 15,729 additional shares. This makes their stake in Lenz Therapeutics total 1,084,404 shares worth $18.7 billion.

On the other hand, there are companies that Sectoral Asset Management Inc is getting rid of from its portfolio. Sectoral Asset Management Inc closed its position in Centene on 13th August 2024. It sold the previously owned 34,000 shares for $2.67 billion. Marina Lalakin also disclosed a decreased stake in Lilly Eli & Co by approximately 0.1%. This leaves the value of the investment at $21.2 billion and 23,415 shares.

One of the smallest hedge funds

The two most similar investment funds to Sectoral Asset Management Inc are Next Capital Management and Hgc Investment Management. They manage $246 billion and $246 billion respectively.


Marina Lalakin investment strategy

Sectoral Asset Management Inc’s portfolio is diversified across 2 sectors. Currently, their heaviest sector is Health Care — making up 44.8% of the total portfolio value. The fund focuses on investments in the United States as 43.3% of the portfolio companies are based in the United States.

The majority of the companies in the fund’s portfolio are large-cap stocks. Stocks with a size of more than $10 billion in market cap make up 29% of the total holdings value. On the other hand, small-cap stocks make up only approximately 0.1% of the portfolio. The average market cap of the portfolio companies is close to $63.6 billion.

The complete list of Sectoral Asset Management Inc trades based on 13F SEC filings

These positions were updated on August 13th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.

Security Shares Owned Value Allocation
Lilly Eli & Co
8.77%
23,415
$21,199,473,000 8.62%
Lenz Therapeutics
1.47%
1,084,404
$18,749,345,000 7.62%
Contineum Thera
Opened
800,887
$14,103,620,000 5.73%
Unitedhealth Grp Inc
15.10%
26,675
$13,584,511,000 5.52%
Merck & Co Inc
No change
86,500
$10,708,700,000 4.35%
Johnson & Johnson
18.81%
56,850
$8,309,196,000 3.38%
Abbvie Inc
27.70%
44,950
$7,709,824,000 3.13%
Abbott Labs
5.69%
66,248
$6,883,830,000 2.80%
Regeneron Pharmctcls
14.63%
6,040
$6,348,221,000 2.58%
Thermo Fisher Sci
4.99%
10,515
$5,814,795,000 2.36%
Boston Scientific Corp.
17.35%
71,476
$5,504,367,000 2.24%
Mineralys Therapeuti
20.55%
438,748
$5,133,352,000 2.09%
Pfizer Inc.
4.22%
181,400
$5,075,572,000 2.06%
Gilead Sciences, Inc.
77.82%
68,825
$4,722,083,000 1.92%
Medtronic Plc
56.50%
59,551
$4,687,259,000 1.90%
AMGEN Inc.
8.61%
14,700
$4,593,015,000 1.87%
Danaher Corp.
No change
17,725
$4,428,591,000 1.80%
Stryker Corp.
94.70%
12,850
$4,372,213,000 1.78%
Vertex Pharma
19.97%
8,650
$4,054,428,000 1.65%
Dexcom Inc
0.77%
32,150
$3,645,167,000 1.48%
Biomarin Pharmac Inc
20.10%
41,260
$3,396,936,000 1.38%
IQVIA Holdings Inc
10.64%
15,600
$3,298,464,000 1.34%
Alnylam Pharmacuetcl
32.39%
12,480
$3,032,640,000 1.23%
Zimmer Biomet Hlds
10.42%
26,650
$2,892,325,000 1.18%
Argenx Se
29.92%
6,522
$2,804,721,000 1.14%
Centene Corp.
Closed
34,000
$2,668,320,000
Boundless Bio Inc
20.28%
682,274
$2,640,400,000 1.07%
Moderna Inc
50.00%
22,110
$2,625,563,000 1.07%
Vaxcyte, Inc.
296.82%
33,730
$2,546,952,000 1.04%
Icon Plc
1.07%
8,028
$2,516,537,000 1.02%
Elevance Health Inc
28.57%
4,500
$2,438,370,000 0.99%
Intuitive Surgic Inc
11.48%
5,400
$2,402,190,000 0.98%
CVS Health Corp
Opened
39,000
$2,303,340,000 0.94%
BioNTech SE
673.48%
27,265
$2,191,015,000 0.89%
Amicus Therapeutics Inc
1.90%
216,844
$2,151,092,000 0.87%
Sarepta Therapeutics Inc
21.95%
13,496
$2,132,368,000 0.87%
GoodRx Holdings, Inc.
17.45%
265,000
$2,067,000,000 0.84%
Ars Pharmaceuticals
15.90%
236,937
$2,016,334,000 0.82%
Progyny Inc
7.89%
70,000
$2,002,700,000 0.81%
Cytokinetics Inc
13.39%
36,883
$1,998,321,000 0.81%
Inari Med Inc
22.86%
40,500
$1,950,075,000 0.79%
Eyepoint Pharma
Closed
92,340
$1,908,668,000
Alphatec Holdings In
Closed
136,000
$1,875,440,000
Option Care Health, Inc.
1.56%
65,000
$1,800,500,000 0.73%
Humana Inc.
No change
4,751
$1,775,211,000 0.72%
Astrazeneca
11.38%
21,650
$1,688,484,000 0.69%
Acelyrin Inc
Closed
244,000
$1,647,000,000
Stevanato Group Spa
Opened
89,000
$1,632,260,000 0.66%
Evolent Health Inc
Opened
84,000
$1,606,080,000 0.65%
Insulet Corporation
59.39%
7,350
$1,483,230,000 0.60%
Edwards Lifescience
No change
15,650
$1,445,591,000 0.59%
iTeos Therapeutics, Inc.
27.62%
96,966
$1,438,975,000 0.58%
Biogen Inc
11.91%
6,137
$1,422,679,000 0.58%
Effector Therapeutic
Closed
95,305
$1,371,439,000
Turnstone Biologics
No change
517,648
$1,356,238,000 0.55%
Olema Pharmaceutical
15.36%
118,480
$1,281,954,000 0.52%
Bristol-Myers Squibb Co.
Opened
30,000
$1,245,900,000 0.51%
Arcus Biosciences Inc
16.29%
78,385
$1,193,804,000 0.49%
Cigna Group (The)
Opened
3,500
$1,156,995,000 0.47%
Moonlake Immunothera
53.71%
21,428
$942,189,000 0.38%
Altimmune Inc
Closed
92,240
$939,003,000
Becton Dickinson
Opened
4,000
$934,840,000 0.38%
Arvinas Inc
28.60%
34,830
$927,175,000 0.38%
Verastem Inc
Closed
74,200
$875,560,000
Cogent Biosciences I
67.54%
85,600
$721,608,000 0.29%
ADC Therapeutics SA
Opened
228,102
$720,802,000 0.29%
Insmed Inc
40.19%
9,821
$658,007,000 0.27%
Illumina Inc
7.48%
5,810
$606,448,000 0.25%
United Therapeutics Corp
29.87%
1,820
$579,761,000 0.24%
Neurocrine Bioscienc
6.20%
3,935
$541,731,000 0.22%
Incyte Corp.
5.32%
8,905
$539,821,000 0.22%
Structure Therapeu
124.09%
13,365
$524,844,000 0.21%
Roivant Sciences Ltd
7.08%
45,957
$485,765,000 0.20%
Ionis Pharmaceutical
4.36%
9,660
$460,396,000 0.19%
Medpace Holdings Inc
14.33%
1,106
$455,506,000 0.19%
Intra Cellular Thera
7.77%
6,530
$447,240,000 0.18%
Royalty Pharma plc
14.26%
16,650
$439,061,000 0.18%
Blueprint Medicines Corp
12.70%
3,850
$414,953,000 0.17%
Alkermes plc
17.57%
16,730
$403,193,000 0.16%
Apellis Pharmaceutic
8.17%
10,460
$401,246,000 0.16%
BridgeBio Pharma Inc
3.54%
15,535
$393,502,000 0.16%
Ascendis Pharma A S
33.53%
2,666
$363,589,000 0.15%
Jazz Pharma Plc
14.38%
3,334
$355,838,000 0.14%
Sanofi
42.15%
7,330
$355,652,000 0.14%
Beigene Limited
33.72%
2,447
$349,113,000 0.14%
Dr Reddys Labs Ltd
18.18%
4,500
$342,855,000 0.14%
Madrigal Pharmaceuti
5.84%
1,065
$298,370,000 0.12%
Vera Therapeutics
82.81%
7,718
$279,237,000 0.11%
Rocket Pharmaceutica
15.40%
12,530
$269,771,000 0.11%
Crinetics Pharmace
Opened
5,800
$259,782,000 0.11%
Exelixis Inc
12.79%
11,460
$257,506,000 0.10%
Revolution Medicin
48.88%
6,600
$256,146,000 0.10%
Denali Therapeutics Inc
Closed
12,081
$247,902,000
Intellia Therapeut
Closed
8,800
$242,088,000
Viatris Inc.
Opened
22,500
$239,175,000 0.10%
Halozyme Therapeutic
32.83%
3,815
$199,753,000 0.08%
Arrowhead Pharmaceut
2.08%
7,522
$195,497,000 0.08%
Summit Therapeutics Inc
92.06%
25,000
$195,000,000 0.08%
Biohaven Ltd
Opened
3,900
$135,369,000 0.06%
Ptc Therapeutics I
Opened
4,300
$131,494,000 0.05%
Scholar Rock Hldg
2.40%
15,030
$125,200,000 0.05%
Perspective Therapeu
Opened
11,000
$109,670,000 0.04%
Legend Biotech Corp
33.33%
2,000
$88,580,000 0.04%
Kyverna Therapeutics
No change
7,000
$52,500,000 0.02%
Zai Lab Ltd
No change
2,000
$34,660,000 0.01%
Grail Inc
Opened
240
$3,689,000 0.00%
No transactions found
Showing first 500 out of 106 holdings